LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 60

Search options

  1. Book ; Online ; E-Book: Myelin

    Zalc, Bernard / Rosier, Florence / Cory, Robert N.

    the brain's supercharger

    2018  

    Title translation La myéline, le turbo du cerveau
    Author's details Bernard Zalc, Florence Rosier ; translated by Robert N. Cory
    Keywords Myelin sheath ; Myelin sheath/Diseases ; Neurophysiology
    Subject code 612.8
    Language English
    Size 1 Online-Ressource (xiv, 308 Seiten), Illustrationen
    Publisher Oxford University Press
    Publishing place New York, NY
    Publishing country United States
    Document type Book ; Online ; E-Book
    Note "French Edition © ODILE JACOB, 2016.". - "French Title: Le Myéline, le turbo du cerveau, by Bernard Zalc and Florence Rosier"
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT019805782
    ISBN 978-0-19-068610-9 ; 9780190686093 ; 0-19-068610-3 ; 019068609X
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article ; Online: One hundred and fifty years ago Charcot reported multiple sclerosis as a new neurological disease.

    Zalc, Bernard

    Brain : a journal of neurology

    2018  Volume 141, Issue 12, Page(s) 3482–3488

    MeSH term(s) Brain/pathology ; History, 19th Century ; Humans ; Male ; Multiple Sclerosis/history ; Multiple Sclerosis/pathology ; Neurology/history
    Language English
    Publishing date 2018-11-21
    Publishing country England
    Document type Biography ; Historical Article ; Journal Article
    ZDB-ID 80072-7
    ISSN 1460-2156 ; 0006-8950
    ISSN (online) 1460-2156
    ISSN 0006-8950
    DOI 10.1093/brain/awy287
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Live-Imaging of Myelin in Animal Models and in Human.

    Zalc, Bernard

    Brain plasticity (Amsterdam, Netherlands)

    2016  Volume 2, Issue 1, Page(s) 1–2

    Language English
    Publishing date 2016-12-21
    Publishing country Netherlands
    Document type Editorial
    ZDB-ID 2827963-3
    ISSN 2213-6312 ; 2213-6304
    ISSN (online) 2213-6312
    ISSN 2213-6304
    DOI 10.3233/BPL-169001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Endogenous clues promoting remyelination in multiple sclerosis.

    Lubetzki, Catherine / Zalc, Bernard / Kremer, David / Küry, Patrick

    Current opinion in neurology

    2022  Volume 35, Issue 3, Page(s) 307–312

    Abstract: Purpose of review: The introduction some 30 years ago of β-interferon, followed by a panel of immunomodulators and immunosuppressants has led to a remarkable improvement in the management of multiple sclerosis (MS) patients. Despite these noticeable ... ...

    Abstract Purpose of review: The introduction some 30 years ago of β-interferon, followed by a panel of immunomodulators and immunosuppressants has led to a remarkable improvement in the management of multiple sclerosis (MS) patients. Despite these noticeable progresses, which lower the number of relapses and thereby ameliorate patients' quality of life, preventing long-term progression of disability is still an unmet need, highlighting the necessity to develop therapeutic strategies aimed at repairing demyelinated lesions and protecting axons from degeneration. The capacity of human brain to self-regenerate demyelinated lesion has opened a field of research aimed at fostering this endogenous potential.
    Recent findings: The pioneer electron microscopic evidence by Périer and Grégoire [Périer O, Grégoire A. Electron microscopic features of multiple sclerosis lesions. Brain 1965; 88:937-952] suggesting the capacity of human brain to self-regenerate demyelinated lesion has opened a field of research aimed at fostering this endogenous potential. Here we review some recently identified mechanisms involved in the remyelination process, focusing on the role of electrical activity and the involvement of innate immune cells. We then provide an update on current strategies promoting endogenous myelin repair.
    Summary: Identification of therapeutic targets for remyelination has opened an active therapeutic field in MS. Although still in early phase trials, with heterogenous efficacy, the door for myelin regeneration in MS is now opened.
    MeSH term(s) Humans ; Multiple Sclerosis/drug therapy ; Myelin Sheath/pathology ; Oligodendroglia/pathology ; Quality of Life ; Remyelination
    Language English
    Publishing date 2022-06-08
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 1182686-1
    ISSN 1473-6551 ; 1350-7540
    ISSN (online) 1473-6551
    ISSN 1350-7540
    DOI 10.1097/WCO.0000000000001064
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Remyelination: a brief history.

    Lubetzki, Catherine / Zalc, Bernard

    The Lancet. Neurology

    2020  Volume 19, Issue 8, Page(s) 649

    Language English
    Publishing date 2020-07-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 2081241-3
    ISSN 1474-4465 ; 1474-4422
    ISSN (online) 1474-4465
    ISSN 1474-4422
    DOI 10.1016/S1474-4422(20)30209-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Conditional Demyelination and Remyelination in a Transgenic Xenopus laevis.

    Mannioui, Abdelkrim / Zalc, Bernard

    Methods in molecular biology (Clifton, N.J.)

    2019  Volume 1936, Page(s) 239–248

    Abstract: Multiple sclerosis (MS) is the first cause of acquired disability progression in the young adult. Pathology of MS associates inflammation, demyelination, and neurodegeneration. The development of immunotherapies, by reducing the relapse rate, has ... ...

    Abstract Multiple sclerosis (MS) is the first cause of acquired disability progression in the young adult. Pathology of MS associates inflammation, demyelination, and neurodegeneration. The development of immunotherapies, by reducing the relapse rate, has profoundly impacted short-term prognosis and patients' quality of life. These anti-inflammatory medications, however, have not proven to be sufficient to prevent long-term disability progression, resulting from axonal transection and neuronal damage, consequences of prolonged demyelination. Promoting remyelination is therefore a key therapeutic strategy to limit handicap progression, and represent the major therapeutic challenge in MS. Here we present a simple, rapid, and cost-effective experimental model developed in Xenopus laevis to screen in vivo molecules promoting remyelination.
    MeSH term(s) Animals ; Animals, Genetically Modified/growth & development ; Disease Models, Animal ; Disease Progression ; Drug Evaluation, Preclinical ; Female ; Male ; Metronidazole/adverse effects ; Multiple Sclerosis/chemically induced ; Multiple Sclerosis/drug therapy ; Myelin Basic Protein/genetics ; Nitroreductases/genetics ; Nitroreductases/metabolism ; Promoter Regions, Genetic ; Remyelination/drug effects ; Small Molecule Libraries/pharmacology ; Xenopus laevis/genetics
    Chemical Substances Myelin Basic Protein ; Small Molecule Libraries ; Metronidazole (140QMO216E) ; Nitroreductases (EC 1.7.-)
    Language English
    Publishing date 2019-02-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-4939-9072-6_14
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Evolution of glial wrapping: A new hypothesis.

    Rey, Simone / Zalc, Bernard / Klämbt, Christian

    Developmental neurobiology

    2020  Volume 81, Issue 5, Page(s) 453–463

    Abstract: Animals are able to move and react in numerous ways to external stimuli. Thus, environmental stimuli need to be detected, information must be processed and finally an output decision must be transmitted to the musculature to get the animal moving. All ... ...

    Abstract Animals are able to move and react in numerous ways to external stimuli. Thus, environmental stimuli need to be detected, information must be processed and finally an output decision must be transmitted to the musculature to get the animal moving. All these processes depend on the nervous system which comprises an intricate neuronal network and many glial cells. In the last decades, a neurono-centric view on nervous system function channeled most of the scientific interest toward the analysis of neurons and neuronal functions. Neurons appeared early in animal evolution and the main principles of neuronal function from synaptic transmission to propagation of action potentials are conserved during evolution. In contrast, not much is known on the evolution of glial cells that were initially considered merely as static support cells. Although it is now accepted that glial cells have an equally important contribution as their neuronal counterpart to nervous system function, their evolutionary origin is unknown. Did glial cells appear several times during evolution? What were the first roles glial cells had to fulfil in the nervous system? What triggered the formation of the amazing diversity of glial morphologies and functions? Is there a possible mechanism that might explain the appearance of complex structures such as myelin in vertebrates? Here, we postulate a common evolutionary origin of glia and depict a number of selective forces that might have paved the way from a simple supporting cell to a wrapping and myelin forming glial cell.
    MeSH term(s) Animals ; Myelin Sheath ; Neuroglia/physiology ; Neurons ; Synaptic Transmission
    Language English
    Publishing date 2020-03-13
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2256184-5
    ISSN 1932-846X ; 1097-4695 ; 1932-8451 ; 0022-3034
    ISSN (online) 1932-846X ; 1097-4695
    ISSN 1932-8451 ; 0022-3034
    DOI 10.1002/dneu.22739
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Monitoring recovery after CNS demyelination, a novel tool to de-risk pro-remyelinating strategies.

    Henriet, Esther / Martin, Elodie M / Jubin, Pauline / Langui, Dominique / Mannioui, Abdelkrim / Stankoff, Bruno / Lubetzki, Catherine / Khakhalin, Arseny / Zalc, Bernard

    Brain : a journal of neurology

    2023  Volume 146, Issue 6, Page(s) 2453–2463

    Abstract: In multiple sclerosis, while remarkable progress has been accomplished to control the inflammatory component of the disease, repair of demyelinated lesions is still an unmet need. Despite encouraging results generated in experimental models, several ... ...

    Abstract In multiple sclerosis, while remarkable progress has been accomplished to control the inflammatory component of the disease, repair of demyelinated lesions is still an unmet need. Despite encouraging results generated in experimental models, several candidates favouring or promoting remyelination have not reached the expected outcomes in clinical trials. One possible reason for these failures is that, in most cases, during preclinical testing, efficacy was evaluated on histology only, while functional recovery had not been assessed. We have generated a Xenopus laevis transgenic model Tg(mbp:GFP-NTR) of conditional demyelination in which spontaneous remyelination can be accelerated using candidate molecules. Xenopus laevis is a classic model for in vivo studies of myelination because tadpoles are translucent. We reasoned that demyelination should translate into loss of sensorimotor functions followed by behavioural recovery upon remyelination. To this end, we measured the swimming speed and distance travelled before and after demyelination and during the ongoing spontaneous remyelination and have developed a functional assay based on the visual avoidance of a virtual collision. Here we show that alteration of these functional and clinical performances correlated well with the level of demyelination and that histological remyelination, assayed by counting in vivo the number of myelinating oligodendrocytes in the optic nerve, translated in clinical-functional recovery. This method was further validated in tadpoles treated with pro-remyelinating agents (clemastine, siponimod) showing that increased remyelination in the optic nerve was associated with functional improvement. Our data illustrate the potential interest of correlating histopathological parameters and functional-clinical parameters to screen molecules promoting remyelination in a simple in vivo model of conditional demyelination.
    MeSH term(s) Animals ; Multiple Sclerosis/pathology ; Oligodendroglia/pathology ; Remyelination/physiology ; Optic Nerve/pathology ; Disease Models, Animal ; Xenopus laevis ; Myelin Sheath/pathology
    Language English
    Publishing date 2023-03-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80072-7
    ISSN 1460-2156 ; 0006-8950
    ISSN (online) 1460-2156
    ISSN 0006-8950
    DOI 10.1093/brain/awad051
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Remyelination in multiple sclerosis: from basic science to clinical translation.

    Lubetzki, Catherine / Zalc, Bernard / Williams, Anna / Stadelmann, Christine / Stankoff, Bruno

    The Lancet. Neurology

    2020  Volume 19, Issue 8, Page(s) 678–688

    Abstract: The treatment of multiple sclerosis has been transformed by the successful development of immunotherapies that efficiently reduce disease activity and related clinical relapses during the relapsing-remitting phase of the disease. However, the prevention ... ...

    Abstract The treatment of multiple sclerosis has been transformed by the successful development of immunotherapies that efficiently reduce disease activity and related clinical relapses during the relapsing-remitting phase of the disease. However, the prevention of disability progression, which is due to axonal and neuronal damage and loss, has yet to be achieved and is therapeutically challenging, particularly during the progressive phase of the disease. One strategy to counteract neurodegeneration is to promote neuroprotection by enhancing myelin regeneration, hence restoring nerve conduction and metabolic support to the axon. Animal studies have provided targets for interventions to improve brain and spinal cord remyelination, paving the way for the translation of this research to humans. From these initial and promising forays, further problems have emerged, including questions on how best to design these clinical trials and appropriately measure the outcomes. Solving these problems will need additional work before efficacious pro-remyelination therapies will be ready for people with multiple sclerosis, but there is a real sense of hope that researchers are getting closer to a successful therapy.
    MeSH term(s) Disease Progression ; Humans ; Multiple Sclerosis/diagnostic imaging ; Multiple Sclerosis/pathology ; Multiple Sclerosis/physiopathology ; Myelin Sheath/physiology ; Remyelination/physiology
    Language English
    Publishing date 2020-07-23
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2081241-3
    ISSN 1474-4465 ; 1474-4422
    ISSN (online) 1474-4465
    ISSN 1474-4422
    DOI 10.1016/S1474-4422(20)30140-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A retroviral link to vertebrate myelination through retrotransposon-RNA-mediated control of myelin gene expression.

    Ghosh, Tanay / Almeida, Rafael G / Zhao, Chao / Mannioui, Abdelkrim / Martin, Elodie / Fleet, Alex / Chen, Civia Z / Assinck, Peggy / Ellams, Sophie / Gonzalez, Ginez A / Graham, Stephen C / Rowitch, David H / Stott, Katherine / Adams, Ian / Zalc, Bernard / Goldman, Nick / Lyons, David A / Franklin, Robin J M

    Cell

    2024  Volume 187, Issue 4, Page(s) 814–830.e23

    Abstract: Myelin, the insulating sheath that surrounds neuronal axons, is produced by oligodendrocytes in the central nervous system (CNS). This evolutionary innovation, which first appears in jawed vertebrates, enabled rapid transmission of nerve impulses, more ... ...

    Abstract Myelin, the insulating sheath that surrounds neuronal axons, is produced by oligodendrocytes in the central nervous system (CNS). This evolutionary innovation, which first appears in jawed vertebrates, enabled rapid transmission of nerve impulses, more complex brains, and greater morphological diversity. Here, we report that RNA-level expression of RNLTR12-int, a retrotransposon of retroviral origin, is essential for myelination. We show that RNLTR12-int-encoded RNA binds to the transcription factor SOX10 to regulate transcription of myelin basic protein (Mbp, the major constituent of myelin) in rodents. RNLTR12-int-like sequences (which we name RetroMyelin) are found in all jawed vertebrates, and we further demonstrate their function in regulating myelination in two different vertebrate classes (zebrafish and frogs). Our study therefore suggests that retroviral endogenization played a prominent role in the emergence of vertebrate myelin.
    MeSH term(s) Animals ; Gene Expression ; Myelin Sheath/metabolism ; Oligodendroglia/metabolism ; Retroelements/genetics ; RNA/metabolism ; Zebrafish/genetics ; Anura
    Chemical Substances Retroelements ; RNA (63231-63-0)
    Language English
    Publishing date 2024-02-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 187009-9
    ISSN 1097-4172 ; 0092-8674
    ISSN (online) 1097-4172
    ISSN 0092-8674
    DOI 10.1016/j.cell.2024.01.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top